SHILPA MEDICARE LIMITED |
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
| 537 INR | -3,12 % |
|
-1,29 % | +62,59 % |
| 09/04 | Shilpa Medicare obtiene el visto bueno del consejo para lanzar la QIP | MT |
| 28/03 | La rama de ciencias de la vida de Shilpa Medicare nombra a su director general | MT |
Resumen de negocios
Número de empleados: 1 179
Ventas por actividad
| INR en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Pharmaceutical Product and Services
99,2
%
| 11 354 | 99,1 % | 10 415 | 99,2 % | -8,27 % |
Others
0,6
%
| 55 | 0,5 % | 67 | 0,6 % | +21,79 % |
Power
0,2
%
| 46 | 0,4 % | 19 | 0,2 % | -58,53 % |
Ventas por región
| INR en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
India
48,6
%
| 4 880 | 42,6 % | 5 106 | 48,6 % | +4,62 % |
Europe
20,3
%
| 3 252 | 28,4 % | 2 131 | 20,3 % | -34,46 % |
United States
15,6
%
| 1 910 | 16,7 % | 1 639 | 15,6 % | -14,16 % |
Rest of World
15,5
%
| 1 414 | 12,3 % | 1 625 | 15,5 % | +14,94 % |
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
| Chief Executive Officer | 63 | 20/11/87 | |
Alpesh Dalal
DFI | Director of Finance/CFO | - | 31/05/21 |
| Chief Tech/Sci/R&D Officer | - | - | |
| Compliance Officer | - | 16/03/22 | |
| Chief Operating Officer | 58 | 01/06/91 | |
Ritu Tiwary
CMP | Compliance Officer | 47 | 23/05/22 |
R. K. Somani
PRN | Corporate Officer/Principal | - | - |
Awez Pathan
PRN | Corporate Officer/Principal | 55 | - |
| Corporate Officer/Principal | 59 | 03/01/08 | |
| Corporate Officer/Principal | 60 | 01/01/18 |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
| Chief Executive Officer | 63 | 20/11/87 | |
| Director/Board Member | 58 | 02/09/21 | |
Arvind Vasudeva
BRD | Director/Board Member | 63 | 02/09/21 |
| Director/Board Member | 76 | 01/07/22 | |
| Chairman | 67 | 23/03/88 | |
| Chief Operating Officer | 58 | 01/06/91 | |
| Director/Board Member | 55 | 11/08/22 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 97 790 908 | 38 408 541 ( 39,28 %) | 0 | 39,28 % |
Información de la empresa
Shilpa Medicare Ltd.
Shilpa House Hyderabad Road
584135, Raichur
+91 85 3223 8704
http://www.vbshilpa.com
Empresas del grupo
| Nombre | Categoría y sector |
|---|---|
FTF Pharma Pvt Ltd.
 FTF Pharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology FTF Pharma Pvt Ltd. engages in the provision of pharmaceutical services. It offers identification of products, regulatory strategy, non-infringing and IP strategy, and bioequivalence and clinical trials. The company was founded by Jayanta Kumar Mandal on June 20, 2012 and is headquartered in Ahmedabad, India. |
Pharmaceuticals: Major
|
Shilpa Biocare Pvt Ltd.
| |
Shilpa Pharma Lifesciences Ltd.
 Shilpa Pharma Lifesciences Ltd. Pharmaceuticals: MajorHealth Technology Part of Shilpa Medicare Ltd., Shilpa Pharma Lifesciences Ltd. is an Indian company that manufactures pharmaceutical products. The private company is based in Raichur, India. The company was founded in 2020. Santosh Kumar Mahil has been the CEO of the company since 2024. |
Pharmaceuticals: Major
|
Ventas por actividad
Ventas por región
Ganancias trimestrales - Tasa de sorpresa
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| +21,85 % | 546 mil M | |
| -4,77 % | 359 mil M | |
| +16,97 % | 323 mil M | |
| +5,69 % | 290 mil M | |
| +13,68 % | 234 mil M | |
| +3,65 % | 198 mil M | |
| -11,12 % | 194 mil M | |
| +8,08 % | 167 mil M | |
| -3,40 % | 157 mil M |
- Bolsa de valores
- Acciones
- Acción SHILPAMED
- Acción SHILPAMED
- Empresa Shilpa Medicare Limited
